SCHEMBL2565975

SCHEMBL2565975

CO[C@@H]1[C@H](O[Si](C)(C)C(C)(C)C)[C@@H](C=O)O[C@H]1n1c(=O)cc[nH]c1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19692983 0.85 — —
SCHEMBL25396598 0.77 DUT (0.47) —
SCHEMBL19709263 0.77 DUT (0.47) —
SCHEMBL15294572 0.77 DUT (0.47) —
SCHEMBL24487841 0.77 DUT (0.47) —
SCHEMBL15283789 0.77 DUT (0.47) —
SCHEMBL19397186 0.77 DUT (0.47) —
SCHEMBL19693019 0.75 — —
SCHEMBL21242188 0.72 — —
SCHEMBL31160262 0.71 TYMP (0.42) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3464313-A1 5'-CYCLO-PHOSPHONATE MODIFIED NUCLEOTIDES Arrowhead Pharmaceuticals, Inc. (US) 2019-04-10 — — EP disclosed
WO-2017214112-A1 5'-CYCLO-PHOSPHONATE MODIFIED NUCLEOTIDES Arrowhead Pharmaceuticals, Inc. (US) 2017-12-14 — — WO disclosed
WO-2011133868-A2 CONFORMATIONALLY RESTRICTED DINUCLEOTIDE MONOMERS AND OLIGONUCLEOTIDES ALNYLAM PHARMACEUTICALS, INC. (US) 2011-10-27 — — WO disclosed
Send feedback